Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yazdan Yazdanpanah

Showing results (1-10 of 423) with videos related to

Pageof 43
Sort By:
Journal of Medical Virology|October 15, 2020
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patientsYazdan Yazdanpanah,
The Journal of Antimicrobial Chemotherapy|February 27, 2004
Costs associated with combination antiretroviral therapy in HIV-infected patientsYazdan Yazdanpanah
Current Opinion in HIV and AIDS|January 6, 2010
Multidrug resistance: a clinical approachYazdan Yazdanpanah
AIDS (London, England)|July 10, 2014
Assessing characteristics of hidden epidemics to design the most efficient HIV testing strategiesYazdan Yazdanpanah, Karen Champenois
Medecine Sciences : M/S|April 29, 2022
[Fighting infectious diseases: A never-ended renewed challenge]Hervé Raoul, Yazdan Yazdanpanah
La Revue Du Praticien|March 14, 2012
[HIV infection]Armelle Pasquet, Yazdan Yazdanpanah
La Revue Du Praticien|June 17, 2006
[When to initiate antiretroviral therapy and what to start with?]Nathalie Viget, Yazdan Yazdanpanah
Presse Medicale (Paris, France : 1983)|February 8, 2006
[Antiretroviral drugs in severe acute respiratory syndrome]Yazdan Yazdanpanah, Benoît Guéry
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 30, 2008
Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysisNicolas Penel, Yazdan Yazdanpanah
Journal of Hepatology|July 31, 2013
Mathematical modeling: a tool for selecting agents with complementary modes of action?Sylvie Deuffic-Burban, Yazdan Yazdanpanah
Pageof 43

Showing results (1-10 of 423) with videos related to

Sort By:
Pageof 43
Journal of Medical Virology|October 15, 2020
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patientsYazdan Yazdanpanah,
The Journal of Antimicrobial Chemotherapy|February 27, 2004
Costs associated with combination antiretroviral therapy in HIV-infected patientsYazdan Yazdanpanah
Current Opinion in HIV and AIDS|January 6, 2010
Multidrug resistance: a clinical approachYazdan Yazdanpanah
AIDS (London, England)|July 10, 2014
Assessing characteristics of hidden epidemics to design the most efficient HIV testing strategiesYazdan Yazdanpanah, Karen Champenois
Medecine Sciences : M/S|April 29, 2022
[Fighting infectious diseases: A never-ended renewed challenge]Hervé Raoul, Yazdan Yazdanpanah
La Revue Du Praticien|March 14, 2012
[HIV infection]Armelle Pasquet, Yazdan Yazdanpanah
La Revue Du Praticien|June 17, 2006
[When to initiate antiretroviral therapy and what to start with?]Nathalie Viget, Yazdan Yazdanpanah
Presse Medicale (Paris, France : 1983)|February 8, 2006
[Antiretroviral drugs in severe acute respiratory syndrome]Yazdan Yazdanpanah, Benoît Guéry
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 30, 2008
Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysisNicolas Penel, Yazdan Yazdanpanah
Journal of Hepatology|July 31, 2013
Mathematical modeling: a tool for selecting agents with complementary modes of action?Sylvie Deuffic-Burban, Yazdan Yazdanpanah
Pageof 43